Aura Biosciences

1 follower


Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach they call molecular surgery.

Industries

Employees

11-50

Links


Org chart

Collapse
Joseph Lyons
Vice President Human Resources
Sharon A. Malia
Vice President, Quality
Balcar Singh
Vice President, Global Product Supply
Manas Ray
Executive Director
Patrick Nealon
Senior Vice President Clinical Development Operations
Mark Plavsic
Chief Technology Officer
Amy Elazzouzi
VP, Finance
Michael Zuccaro
Vice President, Financial Planning & Analysis

Board & advisors